Implementation of a telephone-based secondary preventive intervention after acute coronary syndrome (ACS): Participation rate, reasons for non-participation and 1-year survival

Trials

Volumn 17, Issue 1, 2016, Pages

  Huber, Daniel ^a   Henriksson, Robin ^a   Jakobsson, Stina ^a   Stenfors, Nikolai ^a   Mooe, Thomas ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Acute coronary syndrome; Cardiovascular disease; Implementation; Mortality; Myocardial infarction; Nurse based; Randomized controlled trial; Secondary prevention; Telemedicine; Telephone

Indexed keywords

LIPID;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; EDUCATIONAL STATUS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH STATUS; HEART DISEASE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NURSE; PATIENT ATTITUDE; PATIENT PARTICIPATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL TIME; TELECONSULTATION; TELEPHONE; TELEPHONE BASED SECONDARY PREVENTIVE PROGRAM; TREATMENT WITHDRAWAL; UNIVARIATE ANALYSIS; UNSTABLE ANGINA PECTORIS; VERY ELDERLY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; SECONDARY PREVENTION; STATISTICS AND NUMERICAL DATA;

ACUTE CORONARY SYNDROME; AGED; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; NURSES; PATIENT PARTICIPATION; PROSPECTIVE STUDIES; SECONDARY PREVENTION; TELEPHONE;

EID: 84957864788     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1203-x     Document Type: Article

References (25)

1. Smith Jr SC, Collins A, Ferrari R, Holmes Jr DR, Logstrup S, McGhie DV, et al. Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Circulation. 2012;126(23):2769-75. doi: 10.1161/CIR.0b013e318267e99f.
2. Rossini R, Capodanno D, Lettieri C, Musumeci G, Limbruno U, Molfese M, et al. Long-term outcomes of patients with acute coronary syndrome and nonobstructive coronary artery disease. Am J Cardiol. 2013;112(2):150-5. doi: 10.1016/j.amjcard.2013.03.006.
3. Bjorck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J. 2009;30(9):1046-56. doi: 10.1093/eurheartj/ehn554.
4. Jernberg T, Johanson P, Held C, Svennblad B, Lindback J, Wallentin L, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305(16):1677-84. doi: 10.1001/jama.2011.522.
5. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635-701. doi: 10.1093/eurheartj/ehs092.
6. Rockson SG, deGoma EM, Fonarow GC. Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromes. Cardiovasc Drugs Ther. 2007;21(5):375-88. doi: 10.1007/s10557-007-6043-1.
7. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180-9. doi: 10.1001/jama.295.2.180.
8. Cacoub PP, Zeymer U, Limbourg T, Baumgartner I, Poldermans D, Rother J, et al. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart. 2011;97(8):660-7. doi: 10.1136/hrt.2010.213710.
9. SWEDEHEART. Annual report 2014. http://www.ucr.uu.se/swedeheart/index.php/dokument-sh/arsrapporter. Accessed 22 January 2015.
10. Kotseva K, Wood D, De Bacquer D, De Backer G, Ryden L, Jennings C, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2015. doi: 10.1177/2047487315569401.
11. Gielen S, Landmesser U. The Year in Cardiology 2013: cardiovascular disease prevention. Eur Heart J. 2014;35(5):307-12. doi: 10.1093/eurheartj/eht551.
12. Neubeck L, Redfern J, Fernandez R, Briffa T, Bauman A, Freedman SB. Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review. Eur J Cardiovasc Prev Rehabil. 2009;16(3):281-9. doi: 10.1097/HJR.0b013e32832a4e7a.
13. Kotb A, Hsieh S, Wells GA. The effect of telephone support interventions on coronary artery disease (CAD) patient outcomes during cardiac rehabilitation: a systematic review and meta-analysis. PLoS One. 2014;9(5):e96581. doi: 10.1371/journal.pone.0096581.
14. Bernocchi P, Scalvini S, Bertacchini F, Rivadossi F, Muiesan ML. Home based telemedicine intervention for patients with uncontrolled hypertension - -a real life non-randomized study. BMC Med Inform Decis Mak. 2014;14:52. doi: 10.1186/1472-6947-14-52.
15. Mooe T, Bjorklund F, Graipe A, Huber D, Jakobsson S, Kajermo U, et al. The Nurse-Based Age Independent Intervention to Limit Evolution of Disease After Acute Coronary Syndrome (NAILED ACS) Risk Factor Trial: protocol for a randomized controlled trial. JMIR Res Protoc. 2014;3(3):e42. doi: 10.2196/resprot.3466.
16. Thygesen K, Alpert JS, White HD. Joint ESCAAHAWHFTFftRoMI. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50(22):2173-95. doi: 10.1016/j.jacc.2007.09.011.
17. Winkleby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992;82(6):816-20.
18. Clark AM, Haykowsky M, Kryworuchko J, MacClure T, Scott J, DesMeules M, et al. A meta-analysis of randomized control trials of home-based secondary prevention programs for coronary artery disease. Eur J Cardiovasc Prev Rehabil. 2010;17(3):261-70.
19. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378(9798):1231-43. doi: 10.1016/S0140-6736(11)61215-4.
20. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959-68. doi: 10.1001/jama.2013.184182.
21. Bergstrom G, Redfors B, Angeras O, Dworeck C, Shao Y, Haraldsson I, et al. Low socioeconomic status of a patient's residential area is associated with worse prognosis after acute myocardial infarction in Sweden. Int J Cardiol. 2014;182C:141-7. doi: 10.1016/j.ijcard.2014.12.060.
22. Jelinek MV, Santamaria JD, Best JD, Thompson DR, Tonkin AM, Vale MJ. Reversing social disadvantage in secondary prevention of coronary heart disease. Int J Cardiol. 2014;171(3):346-50. doi: 10.1016/j.ijcard.2013.12.022.
23. Jelinek M, Vale MJ, Liew D, Grigg L, Dart A, Hare DL, et al. The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications - two years follow-up. Heart Lung Circ. 2009;18(6):388-92. doi: 10.1016/j.hlc.2009.06.001.
24. Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, Schron EB, Lindholm LH, Fagard R, et al. Treatment of hypertension in patients 80years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens. 2010;28(7):1366-72. doi: 10.1097/HJH.0b013e328339f9c5.
25. Strandberg TE, Kolehmainen L, Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia: a clinical review. JAMA. 2014;312(11):1136-44. doi: 10.1001/jama.2014.10924.